Impact of Renal Failure on F18-FDG PET/CT Scans

Impact of Renal Failure on F18-FDG PET/CT Scans

OBJECTIVE The current guidelines for 2-deoxy-2-[18F]fluoro-d-glucose PET/CT scanning do not address potential inaccuracies that may arise due to patients with renal failure. We report a retrospective analysis of standard uptake values (SUVs) in patients with and without renal failure in order to warrant a protocol adjustment. METHODS Patients were matched based on age, gender, and BMI all of ...

FDG PETCT in colorectal cancer

Colorectal cancer represents the second most common malignancy worldwide, with approximately one million newly diagnosed cases each year, and is the fourth leading cause of cancer mortality. This article provides an overview of the role of FDG (fluorodeoxyglucose) PET (positron emission tomography) CT (computed tomography) for assessment in patients with colorectal cancer. A summary of key lear...

Reduced-dose [F]-FDG PETCT scanning with current generation PETCT systems

F 18 FDG PETCT detection for liver metastases

Role of F18-FDG-PET/CT in restaging patients affected by renal carcinoma.

BACKGROUND Renalcancers account for around 3% of all cancers and the most common type of (90%) is renal cell carcinoma Five-year survival rate in renal cancer patients is 68.4%. AIM The aim of our study was to establish the role of F18-FDG-PET/CT in restaging patients with renal carcinoma who underwent partial or radical nephrectomy. Secondary aim of the study was to identify histological cha...